H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 17.6% of adults in Memphis have diagnosed diabetes — 5.6 points above the U.S. 12% figure. Census population 633,104. Tennessee Medicare wound biologics: Palmetto GBA (JJ). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Memphis clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Memphis storefront.
Extracellular Matrix (ECM) Therapy in Memphis, TN for clinics & physicians. ECM therapy products provide n… Compliance support & pricing — contact Hawk Medical.
Adult arthritis here is 27.3% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. CDC PLACES (2023, crude) estimates 17.6% of adults in Memphis have diagnosed diabetes — 5.6 points above the U.S. 12% figure. Together those PLACES numbers are why a city of 500k–1M still needs separate PRP and CTP protocols. extracellular matrix therapy inventory is national; utilization is JJ-local.
National Extracellular Matrix (ECM) Therapy notes (how the product actually works)CDC PLACES (2023, crude) estimates 17.6% of adults in Memphis have diagnosed diabetes — 5.6 points above the U.S. 12% figure. Adult obesity in Memphis is 42.1% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. Adult arthritis here is 27.3% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Payer geography: JJ / Palmetto GBA, sibling states AL, GA. Tennessee Department of Health is the public-health home. We will not mash those grains into a fake “demand score.”
If you already buy extracellular matrix therapy elsewhere, use this page as a check: homologous-use language, current Palmetto GBA article IDs, and PLACES 17.6% diabetes as the epidemiologic floor. If that is how you already practice, the catalog will fit.
CDC PLACES (2023, crude prevalence) estimates 17.6% of adults — 5.6 points above the U.S. 12% figure. Obesity is 42.1%; arthritis is 27.3%. That is place-level BRFSS modeling, not a clinic census and not a Memphis trial.
Regulatory lane, storage, and JJ coding. Amniotic products used as 361 HCT/Ps are not “better gauze.” Match wound stage and coverage article before you convert the cart.
Start with the CDC National Diabetes Statistics Report and America's Health Rankings diabetes measure (BRFSS). Tennessee Department of Health is the state public-health home. Those are the citable sources — not this page’s city name in a headline.
Yes. Tissue products come from FDA-registered banks with donor screening and lot traceability. Your receiving SOP should file IFU, lot, and indication with the chart. That packet is what JJ reviewers and surveyors expect — not a brochure.
If you operate in Tennessee and another MAC state, say it on the first call. JJ will not port 1:1. We would rather split utilization than watch a sister clinic copy Memphis tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Memphis, TN.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Memphis is JJ geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Memphis — 5.6 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Tennessee Part B wound biologics follow this contractor (siblings: AL, GA). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Memphis. Useful for joint-program math; still needs a diagnosis and privileging.
No Memphis storefront. Joe Bradley is an active practice owner. extracellular matrix therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.